Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
These medications have transformed the weight management landscape, offering new hope for people struggling with obesity
However, the potential for delaying or preventing the progression of T2DM in patients treated with GIP and GLP-1 remains uncertain, as there is currently no definitive evidence from human studies demonstrating that enhanced incretin activity directly affects -cell mass or alters the progressive loss of insulin secretory capacity in humans
you will take the medication home
It was a little known supplement for blood sugar support, and then it got dubbed Natures Ozempic on social media and it went viral
The dose-response curve for GLP-1 activation is more linear, meaning split dosing is less likely to sacrifice significant efficacy